Back to Search
KEITH KRAMER, DO
DO
Nephrology Physician
NPI: 1588813240IndividualAccepts Medicare
Education
OTHER
Class of 2007
Research & Publications (20)
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
PMID 18048828·J Clin Oncol·2007
3-trial
Isoprenylcysteine carboxyl methyltransferase activity modulates endothelial cell apoptosis.
PMID 12631708·Mol Biol Cell·2003
7-preclinical
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.
PMID 12902911·J Pediatr Hematol Oncol·2003
8-other
Progressive wheeze, dry cough: what lies beneath? Hodgkin's disease.
PMID 11912994·Postgrad Med·2002
5-case
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
PMID 11464881·Med Pediatr Oncol·2001
5-case
Antibody-based diagnostic and therapeutic innovations for human cancer.
PMID 11569318·Compr Ther·2001
1-meta
Curious bloody sputum causes concern. Wegener's granulomatosis.
PMID 11317471·Postgrad Med·2001
5-case
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
PMID 11301399·Cancer·2001
6-review
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.
PMID 11107154·Med Pediatr Oncol·2000
3-trial
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
PMID 19427746·Int J Radiat Oncol Biol Phys·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1009 W SAINT MAARTENS DR
SAINT JOSEPH, MO 64506 - Phone
- (816) 232-8145
Quick Facts
- NPI
- 1588813240
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile